Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Target Validation and Efficacy Study of Metformin in Patients With Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma

NCT07226453 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07226453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Target Validation and Efficacy Study of Metformin in Patients With Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Recruiting
Start date
May 5, 2026
Completion date
March 31, 2030
Enrollment
30 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

posterior fossa ependymal tumor